M+PAC^®

M+PAC^® is an oil-and-water adjuvanted vaccine for control of Mycoplasma hyopneumoniae (M. hyo) in pigs. M. hyo is a major contributor to Porcine Respiratory Disease Complex (PRDC).

Emunade

M+PAC^® incorporates a unique adjuvant, Emunade, to accelerate and prolong immunity to respiratory disease in swine. Emunade helps potentiate the antibody response generated by M+PAC^® while minimizing tissue irritation and enhancing flowability, even in cold temperatures.

Benefits of M+PAC^®

M+PAC^® has test-proven superiority: in tests conducted by independent research facilities, M+PAC^®- vaccinated pigs demonstrated:

• higher antibody titers.
• reduced lung lesion scores.
• less coughing.
• higher cell-mediated immunity (as indicated by increased white blood cell activity).

The result is M+PAC^® is very efficacious and protective against Mycoplasma pneumonia.

Programs

Vaccination with M+PAC^® as a two-dose program: the first 1mL dose is given intramuscularly (IM) at 7 days or more of age and a second dose 1mL dose is given IM 14-28 days later.

Vaccination with M+PAC^® as a one-dose program: M+PAC^® has also been demonstrated to provide excellent disease prophylaxis when administered as a single 2 mL dose IM from 21 days.

M+PAC^® can provide 100% seroconversion, which gives veterinarians an excellent tool for monitoring vaccination compliance. The 6 months duration of immunity with either the one-dose or two-dose program provides protection all the way to market.

For more detail about M+PAC^® see the Description.

Merck Animal Health also has Porcilis M Hyo and Myco Silencer^® ONCE available for the prevention of M. hyo infections.

orcilis M Hyo offers a quick onset of immunity, a 20 week duration of immunity after the second vaccination and no interference by maternal antibodies.

Myco Silencer^® ONCE was specifically developed and designed as a single dose Mycoplasma hyopneumoniae bacterin.

The three vaccines give customers flexibility in their choice of M. hyo control.